These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25385336)

  • 1. Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
    Fujihara K; Palace J
    Nat Rev Neurol; 2014 Dec; 10(12):679-81. PubMed ID: 25385336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
    Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis Spectrum Disorders.
    Weinshenker BG; Wingerchuk DM
    Mayo Clin Proc; 2017 Apr; 92(4):663-679. PubMed ID: 28385199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic criteria and differential diagnosis of neuromyelitis optica].
    Nakashima I
    Nihon Rinsho; 2014 Nov; 72(11):1964-9. PubMed ID: 25518378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD).
    Franciotta D; Gastaldi M; Sala A; Andreetta F; Rinaldi E; Ruggieri M; Leante R; Costa G; Biagioli T; Massacesi L; Bazzigaluppi E; Fazio R; Mariotto S; Ferrari S; Galloni E; Perini F; Zardini E; Zuliani L; Zoccarato M; Giometto B; Bertolotto A
    Neurol Sci; 2017 Oct; 38(Suppl 2):231-236. PubMed ID: 29030768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
    Kitley J; Leite MI; Nakashima I; Waters P; McNeillis B; Brown R; Takai Y; Takahashi T; Misu T; Elsone L; Woodhall M; George J; Boggild M; Vincent A; Jacob A; Fujihara K; Palace J
    Brain; 2012 Jun; 135(Pt 6):1834-49. PubMed ID: 22577216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
    Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
    Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
    Jordan B; Eger K; Kornhuber ME; Zierz S
    Fortschr Neurol Psychiatr; 2008 Jan; 76(1):21-7. PubMed ID: 18189220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic criteria in acute neuromyelitis].
    Panea C; Petrescu S; Monica P; Voinea L; Dascălu AM; Nicolae M; Ungureanu E; Panca A; Grădinaru S
    Oftalmologia; 2007; 51(4):116-20. PubMed ID: 18543687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
    Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
    Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is neuromyelitis optica distinct from multiple sclerosis?: something for "lumpers" and "splitters".
    Frohman EM; Kerr D
    Arch Neurol; 2007 Jun; 64(6):903-5. PubMed ID: 17562944
    [No Abstract]   [Full Text] [Related]  

  • 12. Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets.
    Ip PP; Chung CY; Chang CC; Lee YF; Wang HM; Lian IB; Fann CS; Yang CC; Liao F
    J Neuroimmunol; 2018 May; 318():45-52. PubMed ID: 29455925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature.
    Watanabe M; Furusho K; Takahashi T; Tamaoka A
    Neurologist; 2015 Dec; 20(6):101-3. PubMed ID: 26671741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
    Hyun JW; Jeong IH; Joung A; Kim SH; Kim HJ
    Neurology; 2016 May; 86(19):1772-9. PubMed ID: 27164713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuromyelitis optica is a frequently seen inflammatory demyelinating disease].
    Asgari N; Skejø HP; Lillevang ST; Stenager E
    Ugeskr Laeger; 2013 May; 175(19):1331-5. PubMed ID: 23663369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against aquaporin-4 in neuromyelitis optica: distinction between recurrent and monophasic patients.
    Ketelslegers IA; Modderman PW; Vennegoor A; Killestein J; Hamann D; Hintzen RQ
    Mult Scler; 2011 Dec; 17(12):1527-30. PubMed ID: 21828202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of neuromyelitis optica in the United States: a multicenter analysis.
    Mealy MA; Wingerchuk DM; Greenberg BM; Levy M
    Arch Neurol; 2012 Sep; 69(9):1176-80. PubMed ID: 22733096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
    Wingerchuk DM; Lucchinetti CF
    Curr Opin Neurol; 2007 Jun; 20(3):343-50. PubMed ID: 17495631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical concept, etiology and pathology of neuromyelitis optica].
    Kurosawa K; Fujihara K
    Nihon Rinsho; 2014 Nov; 72(11):1897-902. PubMed ID: 25518368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.